Apiam Animal Health’s Zoono sanitiser a major breakthrough in COVID-19 prevention.
One of Australia’s largest veterinary service providers, Apiam Animal Health, having recently secured distribution rights of a revolutionary surface sanitiser and protection nanotechnology, has had its Z-71 Microbe Shield product approved by Australia’s Therapeutic Goods Administration for use against COVID-19.
The TGA approval comes on the back of research conducted in the United Kingdom against a COVID-19 surrogate, feline coronavirus, where the Z-71 Microbe Shield was able to reduce the viral levels by over 99.99%.
Apiam Managing Director Dr Chris Richards said the biggest difference between this sanitiser and others on the market is that continues to remain effective over time through killing pathogens by mechanical rather than chemical action.
“It has been demonstrated through extensive research over 10 years against a range of pathogens to be effective for up to 30 days,” he said.
Laboratory tests are currently progressing to establish the duration of protection that the Z-71 Microbe Shield product will have against a COVID-19 surrogate. Apiam has demonstrated 30 days pathogen protection in its animal field studies against a similar coronavirus that causes high mortality in young pigs.
“Both mechanical and chemical sanitisers will kill most pathogens pretty much straight away but the fact that it has been tested to be effective against many germs for up to 30 days on surfaces is a major breakthrough,” he said.
Apiam acquired the distribution rights for the livestock and animal health industries in Australia in November last year for the disinfectant technology, which is manufactured in New Zealand by fellow ASX-listed company, Zoono Group Limited.
“We were initially attracted to the Zoono products for use by our network of vets to sanitise and protect piggeries, poultry sheds and livestock systems, as well for use in biosecurity programs with the technology having been proven in laboratory tests in The Netherlands to be effective against the African Swine Fever virus.”
African Swine Fever is a contagious viral disease of domestic and wild pigs. There is no vaccine and kills about 80 per cent of the pigs it infects. On 11 December last year, the Federal Government announced $66.6 million of funding to address the immediate threat of the disease, which has recently been reported as close as Papua New Guinea and Timor-Leste.
Dr Richards said Apiam had also been using its current supply of Z-71 Microbe Shield to sanitise its own offices and veterinary hospitals around the country.
“Veterinary practices are seen as an essential service and we want to ensure that we make it as safe as possible for our staff and clients,” Dr Richards said.
There had been strong demand from both Apiam clients and the greater community for the use of its products, and Apiam was providing fogging services where requested to assist other essential businesses and workplaces to improve their biosecurity and hygiene systems.
Apiam currently had plenty of stock of the Z-71 Microbe Shield and was expecting to get additional supplies of both Z-71 Microbe Shield and Zoono’s hand sanitiser in the coming weeks, which would be available through Apiam clinics and the countryvet.com.au website.